Outbreak & Situation Updates

Jan 23

Outbreak Updates on Kalikot_Solukhumbu_Jajarkot

Outbreak Updates on Kalikot, Solukhumbu & Jajarkot

Jan 21

Updates on Solukhumbu_5 Magh 2074

Updates on Solukhumbu (5 Magh 2074)

Jan 10

Updates from DHO Jajarkot_25 Poush 2074

Updates from DHO Jajarkot (25 Poush 2074)

Jan 8

Updates from DHO Jajarkot_24 Poush 2074

Updates from DHO Jajarkot (24 Poush 2074)

Jan 7

Updates of Jajarkot and Humla_23 Poush 2074

Updates of Jajarkot and Humla (23 Poush 2074)

Aug 20

Health Cluster Coordination Meeting

Aug 19

National WASH Cluster Meeting 17 Aug 2017

National WASH Cluster Meeting

Aug 19

EARLY WARNING AND REPORTING SYSTEM (EWARS) ANNUAL REPORT 2022 & 2023

EARLY WARNING AND REPORTING SYSTEM (EWARS) ANNUAL REPORT 2022 & 2023 analyzes EWARS data from 2022 and 2023, highlighting key trends, seasonal disease patterns, and the performance of the reporting system. In 2022, dengue was the most frequently reported disease nationwide, followed by AGE and SARI. However, provincial variations were observed: SARI was most reported in Koshi, AGE in Madhesh and Lumbini, ILI in Karnali, and scrub typhus in Sudurpaschim. In 2023, dengue remained the most reported disease, with AGE leading in Madhesh, Lumbini, and Karnali, while SARI was the most reported in Sudurpaschim. A comparison of data from both years shows a notable increase in reported cases overall, with significant rises in AGE and SARI, although the proportion of dengue cases slightly decreased.

Nov 4

Measuring access to assistive technology in Nepal

Evidence based research findings on the use, need and unmet need is a key metric for planning and improving access to Assistive Products (AP). It is estimated that only 5-15% of people in low- and middle-income countries (LMICs) who need assistive technology (AT) have access to them with few availabilities, affordability and trained personnel. In Nepal, accurate data on the needs of AP is still not yet known. With a growing population of older age, increasing prevalence of non-communicable diseases in Nepal, the number of people needing AT is certain to rise. Therefore, the study aims to measure access to AT in Nepal. 